[1]
“Tapinarof Cream 1% QD for the Treatment of Plaque Psoriasis: Efficacy and Safety in Two Pivotal Phase 3 Trials”, J of Skin, vol. 4, no. 6, p. s75, Oct. 2020, doi: 10.25251/skin.4.supp.75.